Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125391321 | 12539132 | 1 | I | 20160617 | 0 | 20160707 | 20160707 | DIR | 65.05 | YR | M | N | 78.90000 | KG | 20160630 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125391321 | 12539132 | 1 | PS | CISPLATIN. | CISPLATIN | 1 | 0 | 143 | MG | ||||||||||
| 125391321 | 12539132 | 2 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | 0 | 4020 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125391321 | 12539132 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125391321 | 12539132 | Abdominal pain | |
| 125391321 | 12539132 | Anaemia | |
| 125391321 | 12539132 | Asthenia | |
| 125391321 | 12539132 | Blood magnesium decreased | |
| 125391321 | 12539132 | Blood potassium decreased | |
| 125391321 | 12539132 | Dehydration | |
| 125391321 | 12539132 | Platelet count decreased | |
| 125391321 | 12539132 | Urinary tract infection | |
| 125391321 | 12539132 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125391321 | 12539132 | 1 | 20160613 | 0 | ||
| 125391321 | 12539132 | 2 | 20160613 | 0 |